Vedolizumab-induced acne in inflammatory bowel disease

被引：7
|
作者：
Gilhooley, Eimear [1 ]
Doherty, Glen [2 ]
Lally, Aoife [1 ]
机构：
[1] St Vincents Univ Hosp, Dept Dermatol, Dublin, Ireland
[2] St Vincents Univ Hosp, Dept Gastroenterol, Dublin, Ireland
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2018年 / 57卷 / 06期
关键词：
Acne; inflammatory bowel disease; BINDING;
D O I：
10.1111/ijd.14001
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：752 / 753
页数：2
相关论文
共 50 条
  • [1] Vedolizumab-Induced Acne Fulminans: An Uncommon and Severe Adverse Effect
    Blankenship, Kaitlin
    Burns, Laura
    Scharf, Mark
    CUTIS, 2022, 110 (03): : E19 - E20
  • [2] Vedolizumab-Induced Liver Injury
    Saraiva, Miguel Mascarenhas
    Ribeiro, Tiago
    Dias, Emanuel
    Lopes, Joanne Lopes
    Cardoso, Helder
    Macedo, Guilherme
    GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, 2021, 28 (06) : 410 - 415
  • [3] Vedolizumab-induced cholestatic liver injury
    Rojas-Feria, Maria
    Rodriguez-Fernandez, Miguel
    Castro-Fernandez, Manuel
    Suarez-Garcia, Emilio
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 (01): : 64 - 65
  • [4] VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Haddley, K.
    DRUGS OF TODAY, 2014, 50 (04) : 309 - 319
  • [5] Vedolizumab (Entyvio) for Inflammatory Bowel Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1451): : 86 - 88
  • [6] Inflammatory Bowel Disease and Acne
    Murphy, Colleen L.
    Gibson, Daniel
    Meyers, Lawrence S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (09): : 2370 - 2370
  • [7] Vedolizumab-Induced Reactive Arthritis: A Clinical Vignette
    Shah, Shalin
    Shamah, Steven
    Swaminath, Arun
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S812 - S813
  • [8] A Case of Severe Vedolizumab-induced Liver Injury
    Hsu, Catherine
    Sikafi, Rafid
    Moore-Gillon, Claudia
    Goldin, Robert
    Possamai, Lucia
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (12) : E148 - E149
  • [9] Vedolizumab in the Perioperative Management of Inflammatory Bowel Disease
    Lightner, Amy L.
    Loftus, Edward V., Jr.
    McKenna, Nicholas P.
    Raffals, Laura E.
    CURRENT DRUG TARGETS, 2019, 20 (13) : 1317 - 1322
  • [10] A product review of vedolizumab in inflammatory bowel disease
    Battat, Robert
    Dulai, Parambir S.
    Jairath, Vipul
    Vande Casteele, Niels
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (10) : 2482 - 2490
12345